Human FGF21 ELISA Kit
search
  • Human FGF21 ELISA Kit

Human FGF21 ELISA Kit

Catalog # FM-E101116

Print

$649.00
Quantity

For research use only. Not for diagnostic or therapeutic use, or for human or veterinary use. Sold only to research institutions and qualified laboratory professionals. Not for sale to individuals for personal use.

Assay Range

31.2-2,000 pg/mL  

Sensitivity

10.0 pg/mL

Specificity

No cross-reaction with other related substances detected

Size

96T

Storage

Store at 2 - 8ºC. Keep reconstituted standard and detection Ab at -20 ºC

Assay Principle

Sandwich ELISA

Sample Volume

100 µL final volume, dilution factor varies on samples

Detection Method

Chromogenic

 

 

Kit Components

 

 1. Recombinant Human FGF21  standard: 2 vials

 2. One 96-well plate coated with Human FGF21  Ab

 3. Sample diluent buffer: 12 mL - 1

 4. Detection antibody: 130 µL, dilution 1:100

 5. Streptavidin-HRP: 130 µL, dilution 1:100

 6. Antibody diluent buffer: 12 mL x1   

 7. Streptavidin-HRP diluent buffer: 12 mL x1

 8. TMB developing agent: 10 mL x1

9. Stop solution: 10 mL x1

10. Washing solution (20x): 25 mL x1

 

 

Background

 

Fibroblast growth factor 21 (FGF-21) is a member of the FGF gene family which is characterized by 120 amino acid (aa) core FGF domain that displays a β-trefoil structure. FGF-21 is a member of the FGF-19 subfamily which also includes FGF-19 and FGF-23. Unlike other FGFs, FGF-19 members lack one strand of the β-trefoil and bind poorly to extracellular matrix molecules such as heparin. They are consequently more diffusible than other FGFs. FGF-21 binds FGF receptors (FGF R) indirectly through co-receptors of the klotho family, while it directly binds to β-Klotho via its C-terminal sequence, which is required for signaling through FGF R.  FGF-21 is produced by hepatocytes in response to free fatty acid (FFA) mediated PPARα-RXR activation. This situation occurs during starvation, diabetic ketosis, or following the ingestion of a high-fat/low-carbohydrate or ketogenic diet. Upon FGF-21 secretion, white adipose tissue is induced to release FFAs from triglyceride stores. FGF-21 production is also induced upon differentiation of human or mouse fibroblasts to adipocytes. In adipose tissue, FGF-21 induces glucose uptake in synergy with PPARγ to increase production of the glucose transporter, GLUT1. It is reported that, in diet-induced obese mice and mouse models of diabetes, administration or transgenic overexpression of FGF-21 restores circulating glucose and triglyceride values to near normal and increases insulin sensitivity.

New